Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate (DEHP)

This publication has 44 references indexed in Scilit:

• Chronic Toxicity of Di(2-ethylhexyl)phthalate in Rats
  Toxicological Sciences, 2000
• Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2000
• A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment Guidelines
  Regulatory Toxicology and Pharmacology, 1999
• Oral Toxicity of Bis(2-Ethylhexyl) Phthalate During Pregnancy and Suckling in the Long–Evans Rat
  Food and Chemical Toxicology, 1998
• Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
  Regulatory Toxicology and Pharmacology, 1998
• Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
  Human & Experimental Toxicology, 1994
• Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)
  Biology of the Cell, 1993
• Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
  Published by Elsevier ,1992
• The Potential Role of Chemically Induced Hyperplasia in the Carcinogenic Activity of the Hypolipidemic Carcinogens
  Toxicology and Industrial Health, 1987
• Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients
  Atherosclerosis, 1983